RNA-based therapeutics are transforming medicine, but scaling production efficiently remains a challenge, particularly the ...

The first time Anne-Laure Le Cunff agreed to give a TEDx talk, she was so terrified she barely slept for a month. The idea of getting onstage in front of hundreds of people gave her stomach cramps, ...

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a ...

Despite years of proclaiming that it’s a “builder, not a buyer,” Netflix appears to be warming up to the idea of actually buying something. “We focus on profitable growth and reinvesting in our ...

The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a new study that we ...

The mRNA covid-19 vaccines seem to have an unexpected benefit: extending the lives of people being treated for cancers by boosting the effectiveness of immunotherapy. An analysis of the records of ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. The latest sign of that was Moderna’s presentation here at the European ...

The messenger RNA (mRNA) COVID-19 vaccines were game changing during the course of the pandemic; now another benefit is emerging—the same vaccines are improving how long people with cancer survive ...

Commercially available mRNA vaccines against COVID have been shown to train patients’ immune systems to kill cancer cells. Combining these vaccines with standard-of-care immune therapy overwhelms ...

Oct 22 (Reuters) - Cancer patients who received mRNA-based COVID vaccines within 100 days of starting treatment with widely used immunotherapies were twice as likely to be alive three years after ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...